FDA Inspection 853865 — Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd. — FEI 3003028650

The FDA completed an inspection of Sumitomo Pharma Co., Ltd. on Nov 1, 2013 in Suzuka. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 1, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Suzuka (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.